Seattle Genetics

$76.64
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$1.72 (-2.20%) As of 1:20 PM EDT today
-$1.72 (-2.20%) Today

Why Robinhood?

You can buy or sell SGEN and other stocks, options, ETFs, and crypto commission-free!

About SGEN

Seattle Genetics, Inc. Common Stock, also called Seattle Genetics, is a biotechnology company, which engages in the development and commercialization of antibody-based therapies for the treatment of cancer. Read More Its product Adcetris is an antibody-drug for the treatment of lymphoma. The firm is also advancing a pipeline of novel therapies for solid tumors and blood-related cancers. The company was founded by Clay B. Siegall and H. Perry Fell on July 15, 1997 and is headquartered in Bothell, WA.

Employees
1,302
Headquarters
Bothell, Washington
Founded
1997
Market Cap
13.23B
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
676.52K
High Today
$78.82
Low Today
$76.50
Open Price
$78.33
Volume
159.68K
52 Week High
$84.37
52 Week Low
$50.71

Collections

SGEN Earnings

-$0.75
-$0.53
-$0.30
-$0.08
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Estimated
Actual
Expected Oct 15, After Hours
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.